M J Exports Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.20 Cr
as on 16-11-2024
- Company Age 52 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 198.26 Cr
as on 16-11-2024
- Revenue -42.43%
(FY 2023)
- Profit -183.20%
(FY 2023)
- Ebitda 14.94%
(FY 2023)
- Net Worth -2.28%
(FY 2023)
- Total Assets -2.28%
(FY 2023)
About M J Exports
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 1.20 Cr.
The company has closed loans amounting to ₹198.26 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Amol Shah and Akshay Shah serve as directors at the Company.
- CIN/LLPIN
U17100MH1972PTC015802
- Company No.
015802
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 May 1972
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at M J Exports?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amol Shah  | Director | 28-Dec-1989 | Current |
| Akshay Shah | Director | 09-Oct-2019 | Current |
Financial Performance of M J Exports.
M J Exports Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 42.43% decrease. The company also saw a substantial fall in profitability, with a 183.2% decrease in profit. The company's net worth dipped by a decrease of 2.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of M J Exports?
In 2023, M J Exports had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Eris M. J. Biopharm Private LimitedActive 22 years 4 monthsAmol Shah and Akshay Shah are mutual person
Fine Aromatics And Herbal Extracts Private LimitedActive 20 years 3 monthsAmol Shah is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Icici Bank Limited Creation Date: 09 Sep 2013 | ₹42.00 Cr | Satisfied |
The Dhanalakshmi Bank Ltd. Creation Date: 28 Jul 2004 | ₹1.70 Cr | Satisfied |
Canara Bank Creation Date: 24 Dec 2001 | ₹2.60 Cr | Satisfied |
How Many Employees Work at M J Exports?
M J Exports has a workforce of 3 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of M J Exports, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped M J Exports's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
